2-(1-octynyl)adenosine has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 6 studies
| Studies (2-(1-octynyl)adenosine) | Trials (2-(1-octynyl)adenosine) | Recent Studies (post-2010) (2-(1-octynyl)adenosine) | Studies (2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine) | Trials (2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine) | Recent Studies (post-2010) (2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine) |
|---|---|---|---|---|---|
| 23 | 0 | 3 | 952 | 2 | 169 |
| Protein | Taxonomy | 2-(1-octynyl)adenosine (IC50) | 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine (IC50) |
|---|---|---|---|
| Adenosine receptor A2a | Homo sapiens (human) | 0.019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiru, T; Homma, H; Matsuda, A; Murayama, T; Nomura, Y; Watanabe, Y | 1 |
| Abiru, T; Machida, H; Matsuda, A; Miyashita, T; Watanabe, Y; Yamaguchi, T | 1 |
| Abiru, T; Homma, H; Matsuda, A; Miyasaka, T; Nomoto, R; Shinozaki, M; Watanabe, Y; Yamaguchi, T | 1 |
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Donegan, RK; Lieberman, RL | 1 |
| Harada, N; Katsuragi, T; Murakami, K; Ohshima, K; Okajima, K; Sato, C; Usune, S | 1 |
2 review(s) available for 2-(1-octynyl)adenosine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Drug Discovery; Glaucoma; Humans; Ligands; Protein Kinase Inhibitors; rho-Associated Kinases; Sympathomimetics | 2016 |
4 other study(ies) available for 2-(1-octynyl)adenosine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity.
Topics: Adenosine; Animals; Antihypertensive Agents; Brain; Male; Molecular Structure; Rats; Rats, Inbred SHR; Receptors, Purinergic; Substrate Specificity | 1992 |
Nucleosides and nucleotides. 107. 2-(cycloalkylalkynyl)adenosines: adenosine A2 receptor agonists with potent antihypertensive effects.
Topics: Adenosine; Animals; Antihypertensive Agents; Brain; Cell Membrane; Heart Rate; Hypertension; Molecular Structure; Rats; Rats, Inbred SHR; Receptors, Purinergic; Structure-Activity Relationship | 1992 |
Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects.
Topics: Adenosine; Adenosine Deaminase; Animals; Antihypertensive Agents; Blood Pressure; Brain; Female; Heart Rate; In Vitro Techniques; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Purinergic; Structure-Activity Relationship | 1992 |
Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
Topics: Adenosine; Alkynes; Animals; Calcium; Cells, Cultured; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Ischemia; Leukocyte Elastase; Lipopolysaccharides; Liver; Male; Monocytes; Neutrophil Activation; Peroxidase; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Reperfusion Injury; Triazines; Triazoles; Tumor Necrosis Factor-alpha | 2000 |